If you made any changes in Pure these will be visible here soon.

Research Output 1988 2020

Filter
Article
1988

Human lymphoblastoid interferon in the treatment of hairy cell leukaemia

Pagnucco, G., Castelli, G., Lazzarino, M., Brusamolino, E., Merante, S., Morra, E., Alessandrino, E. P., Bernasconi, P., Corso, A., Castello, A., Coci, A., Magrini, U. & Bernasconi, C., 1988, In : International Journal of Immunotherapy. 4, 3, p. 169-175 7 p.

Research output: Contribution to journalArticle

Hairy Cell Leukemia
Interferon-alpha
Therapeutics
Splenomegaly
Spleen
1992

Mitoxantrone with intermediate-or high-dose ara-c for refractory acute lymphoblastic leukemia and non-hodgkin's lymphoma

Morra, E., Lazzarino, M., Corso, A., Brusamolino, E., Pagnucco, G., Castagnola, C., Bernasconi, P., Santagostino, A., Livraghi, A. & Bernasconi, C., 1992, In : Leukemia and Lymphoma. 7, S2, p. 72-73 2 p.

Research output: Contribution to journalArticle

1993

A protocol for the enrichment of different types of CFU-S from fetal mouse liver

Corso, A., Hogeweg-Platenburg, M. G. C., De Vries, P. & Visser, J. W. M., 1993, In : Haematologica. 78, 1, p. 5-11 7 p.

Research output: Contribution to journalArticle

DIAGNOSI DI LINFOMA NON-HODGKIN IN UN PAZIENTE AFFETTO DA SINDROME DI MARFAN

Translated title of the contribution: Diagnosis of lymphoma in a patient with Marfan syndromeCorso, A., Pagnucco, G., Morra, E. & Bernasconi, C., 1993, In : Minerva Medica. 84, 7-8, p. 417-419 3 p.

Research output: Contribution to journalArticle

The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia: Clinical results in 46 patients

Morra, E., Lazzarino, M., Brusamolino, E., Pagnucco, G., Castagnola, C., Bernasconi, P., Orlandi, E., Corso, A., Santagostino, A. & Bernasconi, C., 1993, In : Cancer. 72, 2, p. 439-445 7 p.

Research output: Contribution to journalArticle

Cytarabine
Leukemia
Central Nervous System
Therapeutics
Methotrexate
1995

Chronic myelogenous leukemia and exposure to ionizing radiation - a retrospective study of 443 patients

Corso, A., Lazzarino, M., Morra, E., Merante, S., Astori, C., Bernasconi, P., Boni, M. & Bernasconi, C., Feb 1995, In : Annals of Hematology. 70, 2, p. 79-82 4 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Ionizing Radiation
Retrospective Studies
Splenomegaly
Mutagens

Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-α therapy

Lazzarino, M., Corso, A., Regazzi, M. B., Iacona, I. & Bernasconi, C., 1995, In : British Journal of Haematology. 90, 4, p. 928-930 3 p.

Research output: Contribution to journalArticle

Acute Promyelocytic Leukemia
Retinoids
Interferons
Pharmacokinetics
Acids
1996

Clinical relevance of all-trans retinoic acid pharmacokinetics and its modulation in acute promyelocytic leukemia

Lazzarino, M., Regazzi, M. B. & Corso, A., 1996, In : Leukemia and Lymphoma. 23, 5-6, p. 539-543 5 p.

Research output: Contribution to journalArticle

1997

Bone marrow T-cell subsets in patients with monoclonal gammopathies: Correlation with clinical stage and disease status

Corso, A., Castelli, G., Pagnucco, G., Lazzarino, M., Bellio, L., Klersy, C. & Bernasconi, C., Jan 1997, In : Haematologica. 82, 1, p. 43-46 4 p.

Research output: Contribution to journalArticle

Paraproteinemias
T-Lymphocyte Subsets
Multiple Myeloma
Bone Marrow Cells
Bone Marrow

The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement

Castagnola, C., Nozza, A., Corso, A. & Bernasconi, C., Sep 1997, In : Haematologica. 82, 5, p. 577-580 4 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Central Nervous System
Leukemia
Cytarabine
Therapeutics
Intracranial Sinus Thrombosis
Remission Induction
Intracranial Thrombosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Asparaginase
1998

A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome

Bernasconi, P., Cavigliano, P. M., Genini, E., Castagnola, C., Malcovati, L., Calatroni, S., Caresana, M., Boni, M., Alessandrino, E. P., Astori, C., Corso, A. & Bernasconi, C., Sep 1998, In : Cancer Genetics and Cytogenetics. 105, 2, p. 182-186 5 p.

Research output: Contribution to journalArticle

Chromosome Deletion
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Chromosomes, Human, Pair 7
Chromosomes, Human, Pair 5

Management of acute promyelocytic leukemia relapse in the ATRA era

Castagnola, C., Lunghi, M., Corso, A., Tajana, M., Zappasodi, P., Dabusti, M., Lazzarino, M. & Bernasconi, C., Aug 1998, In : Haematologica. 83, 8, p. 714-717 4 p.

Research output: Contribution to journalArticle

Acute Promyelocytic Leukemia
Tretinoin
Recurrence
Idarubicin
Drug Therapy

Multiple myeloma in younger patients: The role of age as prognostic factor

Corso, A., Klersy, C., Lazzarino, M. & Bernasconi, C., Feb 1998, In : Annals of Hematology. 76, 2, p. 67-72 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Survival Rate
Creatinine
Multivariate Analysis
Mortality

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: Correlation with tumor parameters and disease activity

Lazzarino, M., Orlandi, E., Klersy, C., Astori, C., Brusamolino, E., Corso, A., Bellio, L., Gargantini, L., Morra, E. & Bernasconi, C., Feb 1 1998, In : Cancer. 82, 3, p. 576-582 7 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Serum
Neoplasms
Histology
Recurrence
1999

Assessment of renal function in patients with multiple myeloma: The role of urinary proteins

Corso, A., Serricchio, G., Zappasodi, P., Klersy, C., Bosoni, T., Moratti, R., Castagnola, C., Lazzarino, M., Pagnucco, G. & Bernasconi, C., Aug 1999, In : Annals of Hematology. 78, 8, p. 371-375 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Creatinine
Kidney
Hexosaminidases
Serum

Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma

Lazzarino, M., Orlandi, E., Montillo, M., Tedeschi, A., Pagnucco, G., Astori, C., Corso, A., Brusamolino, E., Simoncini, L., Morra, E. & Bernasconi, C., 1999, In : Annals of Oncology. 10, 1, p. 59-64 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Cyclophosphamide
Dexamethasone
fludarabine phosphate
Agranulocytosis

Plateau phase in multiple myeloma: An end-point of conventional-dose chemotherapy

Corso, A., Nozza, A., Lazzarino, M., Klersy, C., Zappasodi, P., Arcaini, L. & Bernasconi, C., Apr 1999, In : Haematologica. 84, 4, p. 336-341 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Drug Therapy
Survival
Melphalan
Therapeutics

Transient response of myeloma clone to pamidronate therapy [8]

Corso, A., Astori, C., Orlandi, E., Zappasodi, P., Arcaini, L. & Bemasconi, C., 1999, In : Haematologica. 84, 8, p. 759-760 2 p.

Research output: Contribution to journalArticle

2000

Blood stem cell collections in multiple myeloma: Definition of a scoring system

Corso, A., Caberlon, S., Pagnucco, G., Klersy, C., Zappasodi, P., Alessandrino, E. P., Vanelli, L., Mangiacavalli, S., Lazzarino, M. & Bernasconi, C., 2000, In : Bone Marrow Transplantation. 26, 3, p. 283-286 4 p.

Research output: Contribution to journalArticle

Melphalan
Multiple Myeloma
Platelet Count
Blood Cells
Granulocyte-Macrophage Progenitor Cells

Outcome of patients with refractory/relapsed aml salvaged with the mec (mitoxantrone etoposide cytarabine) regimen

Castagnola, C., Alessandrino, E. P., Pagnucco, G., Bernasconi, P., Lunghi, M., Colombo, A., Brusamolino, E., Bonfichi, M., Corso, A., Lazzarino, M. & Bernasconi, C., 2000, In : Blood. 96, 11 PART II

Research output: Contribution to journalArticle

Mitoxantrone
Cytarabine
Etoposide
Acute Myeloid Leukemia
Refractory materials

Sweet's syndrome and myelodysplasia: Two entities with a common pathogenetic mechanism? A case report

Zappasodi, P., Corso, A. & Del Forno, C., 2000, In : Haematologica. 85, 8, p. 868-869 2 p.

Research output: Contribution to journalArticle

2001

Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients

Corso, A., Arcaini, L., Mangiacavalli, S., Astori, C., Orlandi, E., Lorenzi, A., Passamonti, F., Klersy, C., Pascutto, C., Canevari-Sciorati, A. & Lazzarino, M., 2001, In : Haematologica. 86, 4, p. 394-398 5 p.

Research output: Contribution to journalArticle

Bone Diseases
Multiple Myeloma
Biomarkers
Monoclonal Gammopathy of Undetermined Significance
Osteocalcin

Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: A single center experience

Castagnola, C., Alessandrino, E. P., Lunghi, M., Bernasconi, P., Della Porta, M., Mangiacavalli, S., Colombo, A., Corso, A., Pagnucco, G., Lazzarino, M. & Bernasconi, C., 2001, In : Annals of Hematology. 80, 5, p. 267-271 5 p.

Research output: Contribution to journalArticle

Cell Transplantation
Acute Myeloid Leukemia
Blood Cells
Stem Cells
Consolidation Chemotherapy

DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma

Lazzarino, M., Corso, A., Barbarano, L., Alessandrino, E. P., Cairoli, R., Pinotti, G., Ucci, G., Uziel, L., Rodeghiero, F., Fava, S., Ferrari, D., Fiumanò, M., Frigerio, G., Isa, L., Luraschi, A., Montanara, S., Morandi, S., Perego, D., Santagostino, A., Savarè, M. & 2 others, Vismara, A. & Morra, E., 2001, In : Bone Marrow Transplantation. 28, 9, p. 835-839 5 p.

Research output: Contribution to journalArticle

Etoposide
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Cisplatin

Thalidomide in refractory myeloma patients: Early changes in bone marrow cellularity

Zappasodi, P., Lorenzi, A. & Corso, A., 2001, In : Haematologica. 86, 4, p. 448 1 p.

Research output: Contribution to journalArticle

2002

A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma

Corso, A., Arcaini, L., Caberlon, S., Zappasodi, P., Mangiacavalli, S., Lorenzi, A., Rusconi, C., Troletti, D., Maiocchi, M. A., Pascutto, C., Morra, E. & Lazzarino, M., Oct 2002, In : Haematologica. 87, 10, p. 1041-1045 5 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Poisons
Etoposide
Multiple Myeloma
Cyclophosphamide

Advantages of using thalidomide for the management of patients with refractory myeloma

Corso, A., Lorenzi, A., Orlandi, E., Astori, C., Mangiacavalli, S. & Lazzarino, M., 2002, In : Haematologica. 87, 3, p. 327-328 2 p.

Research output: Contribution to journalArticle

Thalidomide
Outpatients
Clone Cells
Drug Therapy

Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis

Passamonti, F., Malabarba, L., Orlandi, E., Pascutto, C., Brusamolino, E., Astori, C., Baratè, C., Canevari, A., Corso, A., Bernasconi, P., Cazzola, M. & Lazzarino, M., 2002, In : British Journal of Haematology. 116, 4, p. 855-861 7 p.

Research output: Contribution to journalArticle

Pipobroman
Essential Thrombocythemia
Thrombosis
Therapeutics
Platelet Count

Successful therapy with high-dose steroids and cyclosporine for the treatment of carmustine-mediated lung injury

Zappasodi, P., Vitulo, P., Volpini, E., Castagnola, C., Nascimbene, C. & Corso, A., 2002, In : Annals of Hematology. 81, 6, p. 347-349 3 p.

Research output: Contribution to journalArticle

Carmustine
Lung Injury
Cyclosporine
Pneumonia
Steroids

The natural history of a solitary plasmacytoma

Corso, A., 2002, In : British Journal of Haematology. 118, 2, p. 350 1 p.

Research output: Contribution to journalArticle

Urinary proteins and renal dysfunction in patients with multiple myeloma

Corso, A., Zappasodi, P. & Lazzarino, M., 2002, In : Biomedicine and Pharmacotherapy. 56, 3, p. 139-143 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Kidney
Spontaneous Fractures
Proteins
Renal Insufficiency
2003

Early changes in bone marrow morphology induced by thalidomide in patients with refractory myeloma

Corso, A., Lorenzi, A., Zappasodi, P., Invernizzi, R., Vanelli, L. & Lazzarino, M., Aug 1 2003, In : Haematologica. 88, 8, p. 958-960 3 p.

Research output: Contribution to journalArticle

Thalidomide
Bone Marrow
Erythroblasts
Megakaryocytes
Multiple Myeloma

Urinary proteins in multiple myeloma: Correlation with clinical parameters and diagnostic implications

Corso, A., Zappasodi, P., Pascutto, C., Bosoni, T., Mangiacavalli, S., Lorenzi, A., Rusconi, C. & Lazzarino, M., Aug 1 2003, In : Annals of Hematology. 82, 8, p. 487-491 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Kidney
Creatinine
Immunoglobulin G
Proteins
2004

Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone

Corso, A., Lorenzi, A., Terulla, V., Airò, F., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Rusconi, C. & Lazzarino, M., Sep 2004, In : Annals of Hematology. 83, 9, p. 588-591 4 p.

Research output: Contribution to journalArticle

Thrombomodulin
Thalidomide
Dexamethasone
Venous Thrombosis
Combination Drug Therapy

Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls [8]

Corso, A., Dovio, A., Rusconi, C., Sartori, M. L., Klersy, C., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Ventura, M., Angeli, A. & Lazzarino, M., Sep 2004, In : Leukemia. 18, 9, p. 1555-1557 3 p.

Research output: Contribution to journalArticle

The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma

Corso, A., Barbarano, L., Zappasodi, P., Cairoli, R., Alessandrino, E. P., Mangiacavalli, S., Ferrari, D., Fava, S., Fiumanò, M., Frigerio, G., Isa, L., Luraschi, A., Klersy, C., De Paoli, A., Vergani, C., Banfi, L., Perego, D., Ucci, G., Pinotti, G., Savarè, M. & 4 others, Uziel, L., Vismara, A., Morra, E. & Lazzarino, M., Sep 2004, In : Haematologica. 89, 9, p. 1124-1127 4 p.

Research output: Contribution to journalArticle

Etoposide
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Cisplatin
2005

Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection

Corso, A., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Klersy, C., Rusconi, C., Colucci, E., Lorenzi, A., Troletti, D., Consensi, E. & Lazzarino, M., Feb 2005, In : Leukemia Research. 29, 2, p. 159-163 5 p.

Research output: Contribution to journalArticle

Bone Marrow Cells
Stem Cells
Cell Count
Bone Marrow
Multiple Myeloma

Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma

Corso, A., Mangiacavalli, S., Nosari, A., Castagnola, C., Zappasodi, P., Cafro, A. M., Astori, C., Bonfichi, M., Varettoni, M., Rusconi, C., Troletti, D., Pascutto, C., Morra, E. & Lazzarino, M., Dec 2005, In : Bone Marrow Transplantation. 36, 11, p. 951-954 4 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Etoposide
Multiple Myeloma
Cyclophosphamide
Dexamethasone

Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: A possible mechanism for its antitumor effect

Corso, A., Ferretti, E., Lunghi, M., Zappasodi, P., Mangiacavalli, S., De Amici, M., Rusconi, C., Varettoni, M. & Lazzarino, M., Jul 1 2005, In : Cancer. 104, 1, p. 118-125 8 p.

Research output: Contribution to journalArticle

zoledronic acid
Multiple Myeloma
Mesenchymal Stromal Cells
Down-Regulation
Apoptosis

Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment

Corso, A., Ferretti, E. & Lazzarino, M., Jun 2005, In : Hematology. 10, 3, p. 215-224 10 p.

Research output: Contribution to journalArticle

zoledronic acid
Stromal Cells
Multiple Myeloma
Bone Marrow
Plasma Cells
2006

An update of the APEX study

Corso, A., 2006, In : Haematologica Reports. 2, 5, p. 2-4 3 p.

Research output: Contribution to journalArticle

Bortezomib: Introduction

Corso, A., 2006, In : Haematologica Reports. 2, 5, p. 1 1 p.

Research output: Contribution to journalArticle

Changes in multiple myeloma epidemiology in the last thirty years: A single centre experience

Zappasodi, P., Corso, A., Klersy, C., Pica, G., Mangiacavalli, S., Varettoni, M., Rusconi, C., Pascutto, C. & Lazzarino, M., Feb 2006, In : European Journal of Cancer. 42, 3, p. 396-402 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Epidemiology
Therapeutics
Monoclonal Gammopathy of Undetermined Significance
Recurrence

Mucocutaneous paraneoplastic syndromes in hematologic malignancies

Zappasodi, P., Del Forno, C., Corso, A. & Lazzarino, M., Jan 2006, In : International Journal of Dermatology. 45, 1, p. 14-22 9 p.

Research output: Contribution to journalArticle

Thrombomodulin levels are not modified during thalidomide treatment

Zappasodi, P., Mangiacavalli, S., Terulla, V., Airò, F., Klersy, C., Varettoni, M. & Corso, A., Nov 2006, In : European Journal of Haematology. 77, 5, p. 453-454 2 p.

Research output: Contribution to journalArticle

2007
zoledronic acid
Osteonecrosis
Jaw
pamidronate
Multiple Myeloma

Late onset of bortezomib-associated cutaneous reaction following herpes zoster [4]

Varettoni, M., Vassallo, C., Borroni, G., Mangiacavalli, S., Zappasodi, P., Rosso, R., Lazzarino, M. & Corso, A., Apr 2007, In : Annals of Hematology. 86, 4, p. 301-302 2 p.

Research output: Contribution to journalArticle

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

Dimopoulos, M., Spencer, A., Attal, M., Prince, H. M., Harousseau, J. L., Dmoszynska, A., San Miguel, J., Hellmann, A., Facon, T., Foà, R., Corso, A., Masliak, Z., Olesnyckyj, M., Yu, Z., Patin, J., Zeldis, J. B. & Knight, R. D., Nov 22 2007, In : New England Journal of Medicine. 357, 21, p. 2123-2132 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Placebos
Thalidomide
Poisons